Otros idiomas Melodiol Global Health Limited

Acciones

ME1

AU0000282840

Mercado cerrado - Australian S.E. Otros sitios de cotización 08:10:47 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
0,004 ^AUD	+33,33 %		-20,00 %	-90,00 %

29/02	Melodiol Global Health Limited informa de los resultados de ganancias para el año completo finalizado el 31 de diciembre de 2023	CI
2023	Melodiol Global Health Limited anuncia la dimisión de Erlyn Dawson como secretaria conjunta de la empresa	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Melodiol Global's Revenue Surges 79% in Q1	16/04
Melodiol Global Health Subsidiary Health House Australia to Launch Medicinal Cannabis Clinic	09/04
Melodiol Global Health Posts 148% Increase in FY 2023 Revenue to AU$21.6 Million	26/03
Melodiol Global Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023	29/02
Melodiol Unit to Add Cannabis Products Across Six Canadian Provinces	13/02
Melodial's Unit Logs AU$1 Million Revenues in January	07/02
Melodiol Global Health Limited Announces Resignation of Erlyn Dawson as Joint Company Secretary	21/12
Melodiol Global Health Limited Reports Unaudited Revenue Results for the Nine Months of 2023	13/11
Melodiol Global's Canadian Arm Mernova Posts Record Sales for October	02/11
Melodiol Global Health Achieves 80% Remission Rate from Phase Two Hallucinogenic Trial	12/10/23
Melodial's Canadian Arm Mernova Logs Record Sales in Q3	10/10/23
Melodiol Global Health Limited Reports Earnings Results for the Half Year Ended June 30, 2023	31/08/23
Panacea Life Sciences Holdings, Inc. entered into a non-binding LOI to acquire Sierra Sages Herbs, LLC and Halucenex Life Sciences Inc. for $20 million.	02/08/23
Melodiol Logs Strong Start to Q3 with AU$1.6 Million in Revenue and Confirmed Purchase Orders	20/07/23
Melodiol Global Health Limited Announces Revenue Results for Third Quarter of 2023	19/07/23
Melodiol Global Health Triples Q2 Net Sales	13/07/23
Creso Pharma Changes Name to Melodiol Global Health	13/06/23
Creso Pharma Signs Deal to Import Psychedelic Medication into Australia	09/06/23
Creso Pharma's Subsidiary Hires Consultant to Support Licensing Process in Australia, Europe	05/06/23
Creso Pharma Raises AU$2.5 Million Via Share Issue	19/05/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Melodiol Global Health Limited

Acciones

ME1

AU0000282840

Otros idiomas

Filtros